CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome
Immunology
[키워드] A549 cell
Admission
Algorithm
alveolar
analyzed
Anti-viral
assays
Autopsy
Cell culture
chemokine
chemokines
chemotactic
clinical
Cohort
cohort of patient
coronavirus disease
COVID-19
COVID-19 patients
CXCL17
died
ELISA
enrolled
enzyme-linked immunosorbent
evaluated
exhibit
expressed
expression
expression pattern
functions
Future
Hospitalization
humans
immunohistochemistry
incidence
Influenza
influenza A(H1N1)
Ligand
lung
lung tissue
machine-learning
Mexico City
monocyte-derived macrophage
Mortality
motif
myeloid cells
other respiratory infection
pandemic
Patient
patients
Peripheral blood
Peripheral blood sample
Poor
poor prognosis
post-mortem lung
predict
processed
Prognostic value
PTB
pulmonary tuberculosis
Regression analyses
renal
required
respiratory pathogen
respiratory tract
SARS-CoV-2
Seasonal influenza
serum
Serum level
Seven
Specific
specimen
the disease
Tuberculosis
utility
virus infection
was tested
[DOI] 10.3389/fimmu.2021.633297 PMC 바로가기 [Article Type] Immunology
[DOI] 10.3389/fimmu.2021.633297 PMC 바로가기 [Article Type] Immunology